Listeria cerebritis: relapse of infection in renal transplant patients.
In 3 cases of Listeria cerebritis, two of the patients had relapse with cerebritis after antimicrobial therapy for acute Listeria septicemia or meningitis. Each had received ten to 14 days of intravenous penicillin. Relapse occurred with fever and sudden focal cerebral dysfunction. Brain scans showed focal uptake; arteriograms and computerized tomography were normal. Cerebrospinal fluids were nondiagnostic; blood cultures yielded Listeria in two patients. Penicillin treatment for six weeks produced rapid clinical responses that were complete in one and minimal residual in two. Progress brain scans were normal. A relapse rate of 35% is reported in transplant patients with Listeria meningitis and/or bacteremia who are treated for less than three weeks; to our knowledge, cerebritis in such patients has not been reported previously. High-dose penicillin or ampicillin therapy for four to six weeks is recommended for Listeria infections in this select group.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004660:Encephalitis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008088:Listeriosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology*; D008297:Male; D008584:Meningitis, Listeria / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy / Q000382:microbiology*; D011877:Radionuclide Imaging; D012008:Recurrence; D018805:Sepsis / Q000382:microbiology; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents